Adicet Bio, Inc. (ACET) Free cash flow 2017–2025
Adicet Bio, Inc. (ACET) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$97.0MFY2025 · since FY2017: -$11.0M → -$97.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$97.0M | -3.7% |
| FY2024 | -$93.5M | +4.8% |
| FY2023 | -$98.2M | -59.5% |
| FY2022 | -$61.5M | +4.0% |
| FY2021 | -$64.1M | -50.7% |
| FY2020 | -$42.5M | -46.9% |
| FY2019 | -$29.0M | -51.9% |
| FY2018 | -$19.1M | -72.8% |
| FY2017 | -$11.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACET financial trends
ACET RevenueACET Net incomeACET Net marginACET Gross profitACET Gross marginACET Operating incomeACET Operating marginACET Operating cash flowACET Capital expendituresACET Return on equityACET Stock buybacksACET Dividends paidACET Total assetsACET Total liabilitiesACET Shareholders’ equityACET overview →